Does everyone agree it’s just about certainty we will be made to do another phase 2 study for brain Mets but on a larger scale for the FDA?
Does anyone have a case study where the FDA let a company go straight to phase 3 with the amount of patients completing our phase 2 recently completed.?
Does everyone agree it’s just about certainty we will be made to...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.001(3.45%) |
Mkt cap ! $60.84M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.9¢ | 2.7¢ | $262.6K | 9.353M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3390806 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 980416 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| RAD (ASX) Chart |